Literature DB >> 21328028

Investigation of the mechanism of reverse redistribution in thallium-201 myocardial perfusion scintigraphy in patients with suspicion for coronary artery spasm.

Dingcheng Xiang1, Zhenhong Xie, Jinhe Zhang, Jilin Yin.   

Abstract

BACKGROUND: Reverse redistribution (RR) is one of the features on myocardial perfusion scintigraphy (MPS) in patients with coronary artery spasm (CAS). This study was aimed to explore the mechanism of RR in patients with suspicion for CAS. METHODS AND
RESULTS: Thirty patients with RR and suspicion for CAS but without coronary artery stenosis (RR group) and 32 control patients without RR (control group) underwent coronary angiography before and after a dipyridamole administration. Coronary blood flow velocity and myocardial perfusion, as determined by corrected thrombolysis in myocardial infarction (TIMI) frame count (CTFC) and TIMI myocardial perfusion grade (TMPG), were measured. Coronary angiography showed significantly slower blood flow velocity [CTFC (37 ± 6) frame vs (29 ± 7) frame, P < .01] and lower myocardial perfusion [TMPG (2.08 ± 0.38) grade vs (2.55 ± 0.33) grade, P < .05] in RR-related arteries than in RR-unrelated arteries in the RR group. But, there was no significant difference among different coronary artery branches in the control group. After the injection of dipyridamole, CTFC decreased and TMPG increased in the RR group. The decline in CTFC and the increase in TMPG in RR-related arteries were more significant than those in RR-unrelated ones (28% vs 14% and 45% vs 16%, respectively; both P < .01). The endothelin-1/nitric oxide (NO) ratio was significantly higher in the RR group than in the control group before the injection of dipyridamole (2.79 ± 0.37 vs 1.70 ± 0.19, P < .01). After the injection of dipyridamole, the ratio went down in both groups, but the decline was statistically significant in the RR group (2.42 ± 0.33, P < .05) but not in the control group (1.42 ± 0.19, P < .05). Pearson correlation analysis showed that there was a positive correlation between summed rest scores on MPS and the endothelin-1/NO ratio (r = 0.853, P = .000) as well as CTFC (r = 0.808, P = .000) before the injection of dipyridamole in the RR group.
CONCLUSION: Patients with suspicion for CAS may exhibit a mild spasm of RR-related arteries and corresponding microvasculature and a significant imbalance of coronary blood flow velocity and myocardial perfusion at rest between RR-related and RR-unrelated areas. This is overcome by stress-induced hyperemic flow increases and which may account for RR on MPS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21328028     DOI: 10.1007/s12350-011-9342-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  17 in total

1.  Clinical significance of reverse redistribution on resting thallium-201 imaging in patients with vasospastic angina.

Authors:  A Nakano; J D Lee; H Shimizu; A Tsubokawa; H Uzui; T Tsuchida; N Takahashi; Y Yonekura; T Ueda
Journal:  Ann Nucl Med       Date:  2001-02       Impact factor: 2.668

2.  Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects.

Authors:  Nils P Johnson; K Lance Gould
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

3.  Clinical implication of reverse redistribution on 99mTc-sestamibi images for evaluating ischemic heart disease.

Authors:  Ryo Tanaka; Tomoharu Nakamura; Satoru Chiba; Taisuke Ono; Takashi Yoshitani; Akira Miyamoto; Junichi Yamazaki
Journal:  Ann Nucl Med       Date:  2006-06       Impact factor: 2.668

4.  Reverse redistribution during dipyridamole thallium-201 myocardial single photon emission computed tomography in coronary artery disease.

Authors:  J K Lee; C H Kao
Journal:  Kaohsiung J Med Sci       Date:  1996-11       Impact factor: 2.744

5.  Artifactual reverse distribution pattern in myocardial perfusion SPECT with technetium-99m sestamibi.

Authors:  W Araujo; E G DePuey; M Kamran; M Undavia; M Friedman
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

Review 6.  Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomography.

Authors:  H Wieneke; C Zander; E G Eising; M Haude; A Bockisch; R Erbel
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

7.  [Clinical usefulness of delayed exercise images on 99mTc-Tetrofosmin myocardial SPECT in the diagnosis of vasospastic angina pectoris].

Authors:  K Ito; H Sugihara; K Zen; T Hikosaka; Y Adachi; S Yoneyama; S Katoh; T Nakamura; A Azuma
Journal:  Kaku Igaku       Date:  2000-05

8.  Enhanced regional washout of technetium-99m-sestamibi in patients with coronary spastic angina.

Authors:  Souichi Ono; Yasuchika Takeishi; Hiroyuki Yamaguchi; Shigeru Abe; Hidetada Tachibana; Takayuki Sato; Isao Kubota
Journal:  Ann Nucl Med       Date:  2003-07       Impact factor: 2.668

9.  Smoking and hyperlipidemia are important risk factors for coronary artery spasm.

Authors:  Dingcheng Xiang; Franz Xaver Kleber
Journal:  Chin Med J (Engl)       Date:  2003-04       Impact factor: 2.628

10.  [The differential diagnostic value and significance of combined heart stress tests in patients with atypical chest pain].

Authors:  Ding-cheng Xiang; Ji-lin Yin; Ai-ping Teng; Jian-xin He; Zhi-hua Gong; Chang-jiang Hong
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2007-04
View more
  2 in total

1.  "Reverse Redistribution" Pattern on SPECT Myocardial Perfusion Imaging from Endothelial Dysfunction at Rest and from Subendocardial Ischemia.

Authors:  Darko Pucar; Janet Munroe; Lauren Holliday; Hadyn Williams
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

2.  The predictive value of Cardiodynamicsgram in myocardial perfusion abnormalities.

Authors:  Xunde Dong; Jinhe Zhang; Hongji Lai; Min Tang; Shanxing Ou; Jianhong Dou; Cong Wang
Journal:  PLoS One       Date:  2018-12-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.